RU2012149873A - METHOD FOR EVALUATING THE REDUCTION OF SEROTONIN CONTENT IN PERIPHERAL BLOOD OF PREGNANT WOMEN IN THE THIRD TRESTMEST OF GESTURATION IN HERPES-VIRAL INFECTION BY TREATING HUMAN IMMUNOGLOBULIN - Google Patents

METHOD FOR EVALUATING THE REDUCTION OF SEROTONIN CONTENT IN PERIPHERAL BLOOD OF PREGNANT WOMEN IN THE THIRD TRESTMEST OF GESTURATION IN HERPES-VIRAL INFECTION BY TREATING HUMAN IMMUNOGLOBULIN Download PDF

Info

Publication number
RU2012149873A
RU2012149873A RU2012149873/15A RU2012149873A RU2012149873A RU 2012149873 A RU2012149873 A RU 2012149873A RU 2012149873/15 A RU2012149873/15 A RU 2012149873/15A RU 2012149873 A RU2012149873 A RU 2012149873A RU 2012149873 A RU2012149873 A RU 2012149873A
Authority
RU
Russia
Prior art keywords
gestation
trimester
human immunoglobulin
evaluating
reduction
Prior art date
Application number
RU2012149873/15A
Other languages
Russian (ru)
Other versions
RU2530617C2 (en
Inventor
Михаил Тимофеевич Луценко
Ирина Анатольевна Андриевская
Original Assignee
Федеральное государственное бюджетное учреждение "Дальневосточный научный центр физиологии и патологии дыхания" Сибирского отделения РАМН
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное государственное бюджетное учреждение "Дальневосточный научный центр физиологии и патологии дыхания" Сибирского отделения РАМН filed Critical Федеральное государственное бюджетное учреждение "Дальневосточный научный центр физиологии и патологии дыхания" Сибирского отделения РАМН
Priority to RU2012149873/15A priority Critical patent/RU2530617C2/en
Publication of RU2012149873A publication Critical patent/RU2012149873A/en
Application granted granted Critical
Publication of RU2530617C2 publication Critical patent/RU2530617C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Способ оценки снижения содержания серотонина в периферической крови беременных в третьем триместре гестации путем лечения человеческим иммуноглобулином, характеризующегося тем, что при обострении герпес-вирусной инфекции во втором триместре гестации вводится на 16 и 24 неделях беременности внутривенно человеческий иммуноглобулин по 25 мл внутривенно капельно трижды через день, что приводит к снижению в третьем триместре к 36 неделе гестации содержания серотонина до 0,56±0,02 мкмоль/л по сравнению с исходным количеством 1,72±0,09 мкмоль/л во втором триместре гестации при обострении герпес-вирусной инфекции, что предотвращает повреждение органов фетоплацентарной системы.A method of evaluating the reduction of serotonin in the peripheral blood of pregnant women in the third trimester of gestation by treatment with human immunoglobulin, characterized in that, with an exacerbation of herpes virus infection in the second trimester of gestation, a human immunoglobulin of 25 ml is administered intravenously drip three times every other day at 16 and 24 weeks of gestation , which leads to a decrease in the third trimester by week 36 of gestation of the serotonin content to 0.56 ± 0.02 μmol / L compared with the initial amount of 1.72 ± 0.09 μmol / L in the second rum trimester of gestation with exacerbation of herpes virus infection, which prevents damage to the organs of the fetoplacental system.

Claims (1)

Способ оценки снижения содержания серотонина в периферической крови беременных в третьем триместре гестации путем лечения человеческим иммуноглобулином, характеризующегося тем, что при обострении герпес-вирусной инфекции во втором триместре гестации вводится на 16 и 24 неделях беременности внутривенно человеческий иммуноглобулин по 25 мл внутривенно капельно трижды через день, что приводит к снижению в третьем триместре к 36 неделе гестации содержания серотонина до 0,56±0,02 мкмоль/л по сравнению с исходным количеством 1,72±0,09 мкмоль/л во втором триместре гестации при обострении герпес-вирусной инфекции, что предотвращает повреждение органов фетоплацентарной системы. A method of evaluating the reduction of serotonin in the peripheral blood of pregnant women in the third trimester of gestation by treatment with human immunoglobulin, characterized in that, with an exacerbation of herpes virus infection in the second trimester of gestation, a human immunoglobulin of 25 ml is administered intravenously drip three times every other day at 16 and 24 weeks of gestation , which leads to a decrease in the third trimester by week 36 of gestation of the serotonin content to 0.56 ± 0.02 μmol / L compared with the initial amount of 1.72 ± 0.09 μmol / L in the second rum trimester of gestation with exacerbation of herpes virus infection, which prevents damage to the organs of the fetoplacental system.
RU2012149873/15A 2012-11-22 2012-11-22 Method for assessing decay of serotonin content in pregnant women's peripheral blood in third trimester of gestation with herpes virus infection by human immunoglobulin therapy RU2530617C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2012149873/15A RU2530617C2 (en) 2012-11-22 2012-11-22 Method for assessing decay of serotonin content in pregnant women's peripheral blood in third trimester of gestation with herpes virus infection by human immunoglobulin therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2012149873/15A RU2530617C2 (en) 2012-11-22 2012-11-22 Method for assessing decay of serotonin content in pregnant women's peripheral blood in third trimester of gestation with herpes virus infection by human immunoglobulin therapy

Publications (2)

Publication Number Publication Date
RU2012149873A true RU2012149873A (en) 2014-05-27
RU2530617C2 RU2530617C2 (en) 2014-10-10

Family

ID=50775188

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2012149873/15A RU2530617C2 (en) 2012-11-22 2012-11-22 Method for assessing decay of serotonin content in pregnant women's peripheral blood in third trimester of gestation with herpes virus infection by human immunoglobulin therapy

Country Status (1)

Country Link
RU (1) RU2530617C2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998051323A1 (en) * 1997-05-13 1998-11-19 The Regents Of The University Of California Novel antiangiogenic peptide agents and their therapeutic and diagnostic use
RU2306564C1 (en) * 2006-05-10 2007-09-20 ГОУ ВПО "Красноярская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" Method for predicting chronic fetoplacental insufficiency

Also Published As

Publication number Publication date
RU2530617C2 (en) 2014-10-10

Similar Documents

Publication Publication Date Title
NZ716473A (en) Diagnosis and therapy of cancer involving cancer stem cells
EA201990951A1 (en) COMBINATIONS CONTAINING SSAO / VAP-1 INHIBITOR AND SGLT2 INHIBITOR, AND THEIR APPLICATION
EA201491330A1 (en) THERAPEUTICALLY ACTIVE CONNECTIONS AND METHODS OF THEIR USE
EA201690212A8 (en) METHODS OF TREATMENT OR PREVENTION OF OPHTHALMIC PATHOLOGICAL CONDITIONS
EA201590332A1 (en) PHARMACEUTICAL COMBINATIONS CONTAINING B-RAF INHIBITOR, EGFR INHIBITOR AND, OPTIONAL, PI3K-ALPHA INHIBITOR
MX2015007147A (en) A method of reducing brain amyloid plaques using anti-a㟠antibodies.
RU2014150942A (en) TREATMENT OF SIDE EFFECTS IN THE FORM OF MOTOR AND MOTOR DISORDERS RELATED TO THE TREATMENT OF PARKINSON'S DISEASE
EA201400002A1 (en) METHODS TO TREAT DISEASES OF THE RETAIL
JP2016501219A5 (en)
MX2015012444A (en) Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens.
EA201791960A1 (en) APPLICATION OF LEMON-ACID IRON IN THE TREATMENT OF THE CAUSED DEFICIENCY OF THE IRON ANEMIA
RU2014103543A (en) Botulinum toxins for use in the treatment of fatty deposits
RU2012149873A (en) METHOD FOR EVALUATING THE REDUCTION OF SEROTONIN CONTENT IN PERIPHERAL BLOOD OF PREGNANT WOMEN IN THE THIRD TRESTMEST OF GESTURATION IN HERPES-VIRAL INFECTION BY TREATING HUMAN IMMUNOGLOBULIN
FI3137094T3 (en) Treatment and prevention of alzheimer's disease (ad)
RU2013155841A (en) METHOD FOR EARLY DIAGNOSIS OF CHRONIC KIDNEY DISEASE
EA202091446A1 (en) METHODS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES
RU2010133699A (en) METHOD FOR COMBINED TREATMENT OF GLAUCOMA OPTICAL NEUROPATHY
EA201491048A1 (en) CONNECTIONS OF TWO-CELLULAR RNA TO CASP2 AND THEIR APPLICATION
RU2011108787A (en) METHOD FOR TREATING PATIENTS WITH RED PLANE
EA201592159A1 (en) APPLICATION OF TIAZOLOPIRIMIDINONONE FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE INTESTINE
RU2012101073A (en) METHOD FOR TREATING PATIENTS WITH POLYORGANIC OZONE THERAPY PATHOLOGY
EA202091087A1 (en) METHODS FOR REDUCING THE SIDE EFFECTS OF THERAPY WITH ANTIBODY AGAINST CD30-DRUG CONJUGATE
EA201200443A1 (en) COMBINED MEDICINE AND METHOD FOR TREATING VENOUS CEREBRAL DISCRIRCULATION
RU2010147437A (en) METHOD FOR TREATING SHOCK CONDITION IN NEWBORNS WITH SURGICAL PATHOLOGY
RU2010145617A (en) METHOD FOR TREATING PATIENTS WITH CRANIO-BRAIN INJURY ON THE BACKGROUND OF HYPERTENSION SYNDROME IN THE ACUTE PERIOD

Legal Events

Date Code Title Description
FZ9A Application not withdrawn (correction of the notice of withdrawal)

Effective date: 20140519

MM4A The patent is invalid due to non-payment of fees

Effective date: 20141123